Pappas Ventures

Since 1994, Pappas Ventures has been nurturing promising life sciences ideas and delivering superior results to investors and entrepreneurs alike.

At Pappas Ventures, our sole focus is investing in the life sciences – biotechnology, specialty pharmaceuticals, drug delivery, medical devices and related ventures. Our success, however, is not simply a product of investment capital. We bring experience, creativity and passion to each and every partnership. And in so doing, we’re bringing promising technologies to commercial application – from concept to commerce.

Lasmiditan

image of lasmiditan structure

Lasmiditan is a member of a novel chemical class called "ditans." Lasmiditan penetrates the central nervous system (CNS) and selectively targets 5-HT1F receptors expressed in the trigeminal nerve pathway.

Learn More About Lasmiditan